3343-15-5

Usage

Uses

Used in Pharmaceutical Industry:
(S)-9,10-didehydro-N-(1-hydroxyethyl)-6-methylergoline-8beta-carboxamide is used as a potential therapeutic agent for the treatment of neurological and psychiatric disorders. Its action as a partial agonist at serotonin receptors makes it a candidate for further research and development as a medication to address conditions such as migraines and depression.
Used in Research and Development:
In the field of pharmaceutical research and development, (S)-9,10-didehydro-N-(1-hydroxyethyl)-6-methylergoline-8beta-carboxamide is utilized as a subject of interest for exploring its potential applications in the treatment of central nervous system disorders. Its unique pharmacological properties and interactions with serotonin receptors provide a foundation for investigating its efficacy and safety in clinical settings.
Used in Drug Discovery:
(S)-9,10-didehydro-N-(1-hydroxyethyl)-6-methylergoline-8beta-carboxamide is employed in drug discovery processes to identify new compounds with therapeutic potential. Its ergoline-based structure and serotonin receptor modulating capabilities offer a starting point for the development of novel medications aimed at treating a range of neurological and psychiatric conditions.